The Lymphocyte-Specific Tyrosine Protein Kinase p56^lck

References

• Hunter T, Cooper JA. Protein tyrosine kinases. Annu Rev Biochem 1985; 54: 897–930
   PubMed Web of Science ®Google Scholar
• Marth J D, Peet R, Krebs EG, et al. A lymphocyte-specific protein tyrosine kinase gene is rearranged and overexpressed in the murine T cell lymphoma LSTRA. Cell 1985; 43: 393–404
   PubMed Web of Science ®Google Scholar
• Veillette A, Foss F M, Sausville EA, et al. Expression of thelcktyrosine kinase gene in human colon carcinoma and other non-lymphoid human tumor cell lines. Oncogene Res 1987; 1: 357–374
   PubMedGoogle Scholar
• Casnellie J E, Harrison M L, Hellstrom KE, et al. A lymphoma cell line expressing elevated levels of tyrosine protein kinase activity. J Biol Chem 1983; 258: 10738–10742
   PubMed Web of Science ®Google Scholar
• Gacon G, Gisselbrecht S, Piau JP, et al. High level of protein kinase in a murine lymphoma cell line induced by Moloney leukemia virus. EMBO J 1982; 1: 1579–1582
   PubMed Web of Science ®Google Scholar
• Voronova A F, Sefton BM. Expression of a new tyrosine protein kinase is stimulated by retrovirus promoter insertion. Nature 1986; 319: 682–685
   PubMed Web of Science ®Google Scholar
• Abraham N, Veillette A. Activation of p56lckthrough mutation of a regulatory carboxy-terminal tyrosine residue requires intact sites of autophosphorylation and myristylation. Mol Cell Biol 1990; 10, in press
   Google Scholar
• Barber E K, Dasgupta J D, Schlossman SF, et al. The CD4 and CD8 antigens are coupled to a protein-tyrosine kinase (p56lck) that phosphorylates the CD3 comlex. Proc Natl Acad Sci (USA) 1989; 86: 3277–3281
   PubMed Web of Science ®Google Scholar
• Rudd C E, Trevillyan J M, Dasgupta JD, et al. The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T-lymphocytes. Proc Natl Acad Sci (USA) 1988; 85: 5190–5194
   PubMed Web of Science ®Google Scholar
• Veillette A, Bookman M A, Horak EM, et al. The CD4 and CD8 T-cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck. Cell 1988; 55: 301–308
   PubMed Web of Science ®Google Scholar
• Pawson T. Non-catalytic domains of cytoplasmic protein-tyrosine kinases: regulatory elements in signal transduction. Oncogene 1988; 3: 491–495
   PubMed Web of Science ®Google Scholar
• Garvin A M, Pawar S, Marth JD, et al. Structure of the murinelckgene and its rearrangement in a murine lymphoma cell line. Mol Cell Biol 1988; 8: 3058–3064
   PubMed Web of Science ®Google Scholar
• Adler H T, Reynolds P H, Kelley CM, et al. Transcriptional activation oflckby retrovirus promoter insertion between two lymphoid-specific promoters. J Virol 1988; 62: 4113–4122
   PubMed Web of Science ®Google Scholar
• Voronova A F, Buss J E, Patschinsky T, et al. Characterization of the protein apparently responsible for the elevated tyrosine protein kinase activity in LSTRA cells. Mol Cell Biol 1984; 4: 2705–2713
   PubMed Web of Science ®Google Scholar
• Marth J D, Disteche C, Pravtcheva D, et al. Localization of a lymphocyte-specific protein tyrosine kinase gene (lck) at a site of frequent chromosomal abnormalities in human lymphomas. Proc Natl Acad Sci (USA) 1986; 83: 7400–7404
   PubMed Web of Science ®Google Scholar
• Perlmutter R M, Marth J D, Lewis DB, et al. Structure and expression oflcktranscripts in human lymphoid cells. J Cell Biochem 1988; 38: 379–388
   Google Scholar
• Veillette A, Zúñiga-Pflücker J C, Bolen JB, et al. Engagement of CD4 and CD8 expressed on immature thymocytes induces activation of intracellular tyrosine phosphorylation pathways. J Exp Med 1989; 170: 1671–1680
   PubMed Web of Science ®Google Scholar
• Reynolds P J, Lesley J, Trotter J, et al. Changes in the relative abundance of type I and type IIlckmRNA transcipts suggest differential promoter usage during T-cell development. Mol Cell Biol 1990; 10: 4266–4270
   PubMed Web of Science ®Google Scholar
• Sartor O, Gregory F S, Templeton NS, et al. Selective expression of alternativelckmRNAs in human malignant cell lines. Mol Cell Biol 1989; 9: 2983–2988
   PubMed Web of Science ®Google Scholar
• Takadera T, Leung S, Gernone A, et al. Structure of the two promoters of the humanlckgene: Differential accumulation of two classes oflcktranscripts in T cells. Mol Cell Biol 1989; 9: 2173–2180
   PubMed Web of Science ®Google Scholar
• Voronova A F, Adler H T, Sefton BM. Twolcktranscripts containing different 5' untranslated regions are present in T cells. Mol Cell Biol 1987; 7: 4407–4413
   PubMed Web of Science ®Google Scholar
• Marth J D, Lewis D B, Wilson CB, et al. Regulation of pp56lckduring T-cell activation: functional implications for thesrc-like protein tyrosine kinases. EMBO J 1987; 6: 2727–2734
   PubMed Web of Science ®Google Scholar
• Hurley T R, Sefton BM. Analysis of the activity and phosphorylation of thelckprotein in lymphoid cells. Oncogene 1989; 4: 265–272
   PubMed Web of Science ®Google Scholar
• Marth J D, Overell R W, Meier KE, et al. Translational activation of thelckproto-oncogene. Nature 1988; 332: 171–173
   PubMed Web of Science ®Google Scholar
• Kozak M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eurkaryotic ribosomes. Cell 1986; 44: 283–292
   PubMed Web of Science ®Google Scholar
• Marchildon G A, Casnellie J E, Walsh KA, et al. Covalently bound myristate in a lymphoma tyrosine protein kinase. Proc Natl Acad Sci (USA) 1984; 81: 7679–7682
   PubMed Web of Science ®Google Scholar
• Veillette A, Horak I D, Horak EM, et al. Alterations of the lymphocyte-specific protein tyrosine kinase (p56lck) during T-cell activation. Mol Cell Biol 1988; 8: 4353–4361
   PubMed Web of Science ®Google Scholar
• Danielian S, Fagard R, Alcover A, et al. The lymphocyte-specific protein tyrosine kinase p56lckis hyperphosphorylated on serine and tyrosine residues within minutes after activation via T cell receptor or CD2. Eur J Immunol 1989; 19: 2183–2189
   PubMed Web of Science ®Google Scholar
• Marth J D, Lewis D B, Cooke MP, et al. Lymphocyte activation provokes modification of a lymphocyte-specific protein tyrosine kinase (p56lck). J Immunol 1989; 142: 2430–2437
   PubMed Web of Science ®Google Scholar
• Veillette A, Horak I D, Bolen JB. Post-translational alterations of the tyrosine kinase p56lckin response to activators of protein kinase C. Oncogene Res 1988; 2: 385–401
   PubMedGoogle Scholar
• Casnellie J E, Lamberts RJ. Tumour promoters cause changes in the state of phosphorylation and apparent molecular weight of a tyrosine protein kinase in T lymphocytes. J Biol Chem 1986; 261: 4921–4925
   PubMed Web of Science ®Google Scholar
• Casnellie JE. Sites of in vivo phosphorylation of the T cell tyrosine protein kinase in LSTRA cells and their alteration by tumor-promoting phorbol esters. J Biol Chem 1987; 262: 9859–9864
   PubMed Web of Science ®Google Scholar
• Luo K, Sefton BM. Analysis of the sites in the p56lckwhose phosphorylation is induced by tetradecanoyl phorbol acetate. Oncogene 1990; 5: 803–808
   PubMed Web of Science ®Google Scholar
• Amrein K E, Sefton BM. Mutation of a site of tyrosine phosphorylation in the lymphocyte-specific tyrosine protein kinase, p56lckreveals its oncogenic potential in fibroblasts. Proc Natl Acad Sci (USA) 1988; 85: 4247–4251
   PubMed Web of Science ®Google Scholar
• Marth J D, Cooper J A, King CS, et al. Neoplastic transformation induced by an activated lymphocyte-specific protein tyrosine kinase (pp56lck). Mol Cell Biol 1988; 8: 540–550
   PubMed Web of Science ®Google Scholar
• Veillette A, Bolen J B, Bookman MA. Alterations in tyrosine protein phosphorylation induced by antibody-mediated cross-linking of the CD4 receptor of T lymphocytes. Mol Cell Biol 1989; 9: 4441–4446
   PubMed Web of Science ®Google Scholar
• Veillette A, Fournel M. The CD4 associated tyrosine protein kinase p56lckis positively regulated through its site of autophosphorylation. Oncogene 1990; 5, in press
   Google Scholar
• Swain SL. T-cell subsets and the recognition of MHC class. Immunol Rev 1983; 74: 129–142
   PubMed Web of Science ®Google Scholar
• Gay D, Maddon P, Sekaly R, et al. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen. Nature 1987; 328: 626–629
   PubMed Web of Science ®Google Scholar
• Marrack P, Endres R, Shimonkevitz R, et al. The major histocompatibility complex-restricted antigen receptor on T-cells. II. Role of the L3T4 product. J Exp Med 1983; 158: 1077–1091
   PubMed Web of Science ®Google Scholar
• Bank I, Chess L. Perturbation of the T4 molecules transmits a negative signal in T-cells. J Exp Med 1985; 162: 1294–1303
   PubMed Web of Science ®Google Scholar
• Ledbetter J A, June C H, Rabinovitch PS, et al. Signal transduction through CD4 receptors: stimulatory vs. inhibitory activity is regulated by CD4 proximity to the CD3/T cell receptor. Eur J Immunol 1988; 18: 525–532
   PubMed Web of Science ®Google Scholar
• Rosoff P M, Burakoff S J, Greenstein JL. The role of the L3T4 molecule in mitogen and antigen-activated signal transduction. Cell 1987; 49: 845–853
   PubMed Web of Science ®Google Scholar
• Saizawa K, Rojo J, Janeway CA. Evidence for a physical association of CD4 and the CD3β T-cell receptor. Nature 1987; 328: 260–263
   PubMed Web of Science ®Google Scholar
• Wassmer P, Chan C, Logdberg L, et al. Role of the L3T4 antigen in T-cell activation. II. Inhibition of T-cell activation by monoclonal anti-L3T4 antibodies in the absence of accessory cells. J Immunol 1985; 135: 2237–2242
   PubMed Web of Science ®Google Scholar
• Veillette A, Bookman M A, Horak EM, et al. Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosine-protein kinase p56lck. Nature 1989; 338: 257–259
   PubMed Web of Science ®Google Scholar
• June C H, Fletcher M C, Ledbetter JA, et al. Increases in tyrosine phosphorylation are detectable before phospholipase C activation after T cell receptor stimulation. J Immunol 1990; 144: 1591–1599
   PubMed Web of Science ®Google Scholar
• Williams A F, Barclay AN. The immunoglobulin superfamily—domains for cell surface recognition. Ann Rev Immunol 1988; 6: 381–405
   PubMed Web of Science ®Google Scholar
• De Santo J P, Knowles R W, Flomenberg N. The human Lyt-3 molecule requires CD8 for cell surface expression. EMBO J 1988; 7: 3465–3470
   PubMed Web of Science ®Google Scholar
• Littman DR. The structure of the CD4 and CD8 genes. Ann Rev Immunol 1987; 5: 561–584
   PubMed Web of Science ®Google Scholar
• Norment A M, Littman DR. A second subunit of CD8 is expressed in human T cells. EMBO J 1988; 7: 3433–3439
   PubMed Web of Science ®Google Scholar
• Shaw A S, Amrein K E, Hammond C, et al. Thelcktyrosine protein kinase interacts with the cytoplasmic tail of the CD4 glycoprotein through its unique amino-terminal domain. Cell 1989; 59: 627–636
   PubMed Web of Science ®Google Scholar
• Shaw A S, Chalupny J, Whitney JA, et al. Short related sequences in the cytoplasmic domains of CD4 and CD8 mediate binding to the amino-terminal domain of the p56lcktyrosine protein kinase. Mol Cell Biol 1990; 10: 1853–1862
   PubMed Web of Science ®Google Scholar
• Turner J M, Brodsky M H, Irving BA, et al. Interaction of the unique N-terminal region of tyrosine kinase p56lckwith cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs. Cell 1990; 60: 755–765
   PubMed Web of Science ®Google Scholar
• Veillette A, Sleckman B P, Ratnofsky S, et al. The cytoplasmic domain of CD4 is required for stable association with the lymphocyte-specific tyrosine protein kinase p56lck. Eur J Immunol 1990; 20: 1397–1400
   PubMed Web of Science ®Google Scholar
• Sleckman B P, Peterson A, Foran JA, et al. Functional analysis of the cytoplasmic domain-deleted mutant of the CD4 molecule. J Immunol 1988; 141: 49–54
   PubMed Web of Science ®Google Scholar
• Zamoyska R, Derham P, Gorman SD, et al. Inability of the CD8α' polypeptides to associate with p56lckcorrelates with impaired function in vitro and lack of expression in vivo. Nature 1989; 342: 278–281
   PubMed Web of Science ®Google Scholar
• Tr Hurley, Luo K, Sefton BM. Activators of protein kinase C induce dissociation of CD4, but not CD8, from p56lck. Science 1989; 245: 407–409
   PubMed Web of Science ®Google Scholar
• Thomas M. The leukocyte common antigen family. Annu Rev Immunol 1989; 7: 339–369
   PubMed Web of Science ®Google Scholar
• Koretzky G A, Picus J, Thomas ML, et al. Tyrosine phosphatase CD45 is essential for coupling T-cell antigen receptor to the phosphatidylinositol pathway. Nature 1990; 346: 66–68
   PubMed Web of Science ®Google Scholar
• Pingel J T, Thomas ML. Evidence that the leukocyte-common antigen is required for antigen induced T lymphocyte proliferation. Cell 1989; 58: 1055–1065
   PubMed Web of Science ®Google Scholar
• Tonks N K, Charbonneau H, Diltz CD, et al. Demonstration that the leukocyte common antigen CD45 is a protein tyrosine phosphatase. Biochemistry 1988; 27: 8695–8701
   PubMedGoogle Scholar
• Ostergaard H L, Shackelford D A, Hurley TR, et al. Expression of CD45 alters phosphorylation of thelck-encoded tyrosine protein kinase in murine lymphoma T-cell lines. Proc Natl Acad Sci (USA) 1989; 86: 8959–8963
   PubMed Web of Science ®Google Scholar
• Mustelin T, Coggeshall K M, Altman A. Rapid activation of the T cell tyrosine protein kinase p56lckby the CD45 phosphotyrosine phosphatase. Proc Natl Acad Sci (USA) 1989; 86: 6302–6306
   PubMed Web of Science ®Google Scholar
• Mustelin T, Altman A. Dephosphorylation and activation of the T cell tyrosine kinase p56lckbyt he leukocyte common antigen (CD45). Oncogene 1990; 5: 809–813
   PubMed Web of Science ®Google Scholar
• Ostergaard H L, Trowbridge IS. Coclustering CD45 with CD4 or CD8 alters the phosphorylation and kinase activity of p56lck. J Exp Med 1990; 172: 347–350
   PubMed Web of Science ®Google Scholar